Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Invested Capital (2018 - 2025)

Historic Invested Capital for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $485.1 million.

  • Health Catalyst's Invested Capital fell 3071.25% to $485.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $485.1 million, marking a year-over-year decrease of 3071.25%. This contributed to the annual value of $747.6 million for FY2024, which is 2565.14% up from last year.
  • As of Q3 2025, Health Catalyst's Invested Capital stood at $485.1 million, which was down 3071.25% from $500.6 million recorded in Q2 2025.
  • In the past 5 years, Health Catalyst's Invested Capital registered a high of $759.7 million during Q1 2025, and its lowest value of $425.0 million during Q4 2022.
  • For the 5-year period, Health Catalyst's Invested Capital averaged around $612.2 million, with its median value being $617.1 million (2023).
  • Its Invested Capital has fluctuated over the past 5 years, first soared by 11266.43% in 2021, then plummeted by 3954.68% in 2022.
  • Over the past 5 years, Health Catalyst's Invested Capital (Quarter) stood at $703.0 million in 2021, then plummeted by 39.55% to $425.0 million in 2022, then soared by 39.99% to $595.0 million in 2023, then rose by 25.65% to $747.6 million in 2024, then crashed by 35.11% to $485.1 million in 2025.
  • Its Invested Capital was $485.1 million in Q3 2025, compared to $500.6 million in Q2 2025 and $759.7 million in Q1 2025.